Are baseline cardiac studies, such as echocardiography (echo), necessary for a 40-year-old patient with non-vascular Ehlers-Danlos Syndrome (EDS) who is otherwise asymptomatic and has no significant cardiac history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Baseline Cardiac Studies in 40-Year-Old Non-Vascular EDS Patients

Baseline echocardiography is not routinely indicated for asymptomatic 40-year-old patients with non-vascular (hypermobile or classical) Ehlers-Danlos syndrome who have no cardiac symptoms or family history of aortic dissection.

Evidence-Based Rationale

Guideline Recommendations for EDS

The 2003 ACC/AHA echocardiography guidelines specifically address EDS, stating that echocardiography is indicated for "presence of a syndrome associated with cardiovascular disease and dominant inheritance or multiple affected family members (eg, Marfan syndrome or Ehlers-Danlos syndrome)" 1. However, this recommendation was written before the 2017 nosology update that distinguished vascular EDS from hypermobile/classical types, and the guideline groups vascular and non-vascular EDS together without differentiation 1.

The critical distinction is that vascular EDS (type IV) carries significant cardiovascular risk, while hypermobile and classical EDS (types I, II, III) have substantially lower cardiac involvement 2, 3.

Contemporary Research Evidence

The most recent and highest-quality study directly addressing this question is the 2024 pediatric longitudinal echocardiography study in hypermobile EDS patients 2. This study found:

  • Only 15/225 (6.7%) had initial aortic root Z-scores >2.0, with none exceeding Z-score >3.0 2
  • On serial follow-up, aortic root Z-scores declined significantly over time 2
  • Final examination showed only 9/225 (4.0%) with Z-score >2.0, not statistically different from the general population 2
  • No aortic dissections occurred in first- or second-degree relatives 2
  • The authors explicitly concluded: "in the absence of other cardiac findings or suspicion for another disorder, echocardiography is not required in hEDS" 2

Supporting Evidence from Adult Studies

A 1997 British study of 33 EDS patients (primarily types I, II, III) using modern two-dimensional echocardiography found 3:

  • Echocardiographic abnormalities in only 12.1% of EDS patients versus 6.7% of controls (not statistically significant) 3
  • Mitral valve prolapse in 6.1% of EDS patients versus 7% of controls 3
  • No patients with type IV EDS had any echocardiographic abnormality 3
  • No patients had mean aortic dimensions outside the normal range 3

The 2022 adult study of 258 patients with hEDS/HSD found 4:

  • Mitral valve prolapse in 7.5% and thoracic aortic dilatation in 15.2% 4
  • Aortic dilatation was mild in >90% of females 4
  • Cardiovascular manifestations in adults with hEDS/HSD, especially females, are typically mild 4

When Baseline Echocardiography IS Indicated

Obtain baseline echocardiography if any of the following are present:

  • Cardiac symptoms: chest pain, palpitations, dyspnea, syncope, or exercise intolerance 1, 3
  • Family history of aortic dissection in first- or second-degree relatives 2
  • Abnormal cardiac examination: murmur suggesting valvular disease, signs of heart failure, or irregular rhythm 1
  • Suspicion for vascular EDS (type IV) rather than hypermobile/classical types 3
  • Multiple affected family members with documented cardiac involvement 1

Important Clinical Pitfalls

Overdiagnosis of Mitral Valve Prolapse

Seven patients in the 1997 study had been previously diagnosed with MVP, but only two had true MVP using current echocardiographic criteria 3. This highlights the risk of overdiagnosis with older M-mode techniques or clinical examination alone 3.

Distinguishing EDS Subtypes

The older 1980 study showing high cardiovascular abnormality rates (35 cardiac/great vessel abnormalities in 19 hospitalized patients) 5 represents selection bias from hospitalized patients and predates modern EDS classification 5. These findings should not be extrapolated to asymptomatic outpatients with confirmed non-vascular EDS 2, 3.

Cardiac Symptoms Are Common But Non-Specific

In the 1997 study, cardiac symptoms were significantly more frequent in EDS patients than controls (atypical chest pain 48%, palpitations 39%, exertional dyspnea 30%) 3, yet objective cardiac abnormalities were not increased 3. Symptoms alone without examination findings do not mandate echocardiography in this population 3.

Practical Algorithm for the 40-Year-Old Patient

Step 1: Confirm EDS subtype is non-vascular (hypermobile or classical, not vascular type IV)

Step 2: Obtain detailed cardiac history:

  • Any chest pain, palpitations, dyspnea, syncope, or exercise intolerance? 3
  • Family history of aortic dissection or sudden cardiac death? 2

Step 3: Perform cardiovascular examination:

  • Auscultate for murmurs suggesting valvular disease 1
  • Assess for signs of heart failure or arrhythmia 1

Step 4:

  • If history and examination are normal: No baseline echocardiography needed 2
  • If any abnormality detected: Obtain baseline echocardiography 1

Surveillance Strategy If Baseline Echo Is Obtained

If echocardiography is performed and shows mild abnormalities (aortic root Z-score >2.0 but <3.0, mild MVP), the 2024 study demonstrates that serial Z-scores decline over time in hEDS 2. Follow the general cardiology guidelines for mild valve disease: repeat every 2-3 years if stable and asymptomatic 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Echocardiogram Validity Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Does a patient with Ehlers-Danlos syndrome (EDS) need an Echocardiogram (ECHO) in the Emergency Room (ER)?
How often should a transthoracic echocardiogram (TTE) be performed in patients with Ehlers-Danlos syndrome?
What is the management approach for Ehlers-Danlos syndrome (EDS) patients with elevated tryptase levels who are at risk of or have developed heart disease?
What is the recommended management approach for a patient with suspected Marfan or Ehlers-Danlos Syndrome, presenting with gastrointestinal problems, joint hypermobility, easy bruising, disproportionate tall stature, lower back pain, lumbar striae distensae, vision problems, and malabsorption issues, with a normal ECHO (Echocardiogram)?
What are the imaging guidelines for patients with non-vascular Ehlers-Danlos Syndrome (EDS), specifically those with hypermobile or classical EDS?
What are the symptoms of urachal cysts?
What adjustment should be made to the levothyroxine (T4) dose for a patient with hypothyroidism taking 100mcg daily, with a Thyroid-Stimulating Hormone (TSH) level of 1.19 and a free Thyroxine (T4) level of 0.6?
What is the best course of treatment for a male patient with oligoasthenozoospermia, elevated Follicle-Stimulating Hormone (FSH) levels, normal Luteinizing Hormone (LH) levels, and normal testosterone levels?
What is the appropriate workup and management for a patient with atypical pneumonia (PNA) and lung nodules?
Which statin (HMG-CoA reductase inhibitor) has the least myotoxic effect in patients at risk of myopathy?
What is the initial management approach for a newborn presenting with respiratory distress?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.